PHARMACOKINETICS AND EFFECTS OF RECOMBINANT-HUMAN-ERYTHROPOIETIN AFTER INTRAVENOUS AND SUBCUTANEOUS INJECTIONS IN HEALTHY-VOLUNTEERS

被引：0
作者：
MCMAHON, FG [1 ]
VARGAS, R [1 ]
RYAN, M [1 ]
JAIN, AK [1 ]
ABELS, RI [1 ]
PERRY, B [1 ]
SMITH, IL [1 ]
机构：
[1] ROBERT WOOD JOHNSON PHARMACEUT RES INST, RARITAN, NJ USA
来源：
BLOOD | 1990年 / 76卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1718 / 1722
页数：5
相关论文
共 12 条
  • [1] BOELAERT JR, 1989, PERITON DIALYSIS INT, V9, P95
  • [2] BOMMER J, 1988, LANCET, V2, P406
  • [3] BENEFITS AND RISKS OF PROTRACTED TREATMENT WITH HUMAN RECOMBINANT ERYTHROPOIETIN IN PATIENTS HAVING HEMODIALYSIS
    CASATI, S
    PASSERINI, P
    CAMPISE, MR
    GRAZIANI, G
    CESANA, B
    PERISIC, M
    PONTICELLI, C
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 1987, 295 (6605): : 1017 - 1020
  • [4] DEVELOPMENT OF RADIOIMMUNOASSAYS FOR HUMAN ERYTHROPOIETIN USING RECOMBINANT ERYTHROPOIETIN AS TRACER AND IMMUNOGEN
    EGRIE, JC
    COTES, PM
    LANE, J
    DAS, REG
    TAM, RC
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1987, 99 (02) : 235 - 241
  • [5] CORRECTION OF THE ANEMIA OF END-STAGE RENAL-DISEASE WITH RECOMBINANT-HUMAN-ERYTHROPOIETIN - RESULTS OF A COMBINED PHASE-I AND PHASE-II CLINICAL-TRIAL
    ESCHBACH, JW
    EGRIE, JC
    DOWNING, MR
    BROWNE, JK
    ADAMSON, JW
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 316 (02) : 73 - 78
  • [6] FU JS, 1988, J LAB CLIN MED, V111, P669
  • [7] Gibaldi M., 1982, PHARMACOKINETICS, Vsecond
  • [8] RAINE AEG, 1988, LANCET, V1, P97
  • [9] REISSMANN KR, 1965, J LAB CLIN MED, V65, P967
  • [10] SPIVAK JL, 1989, BLOOD, V73, P90
12